Luyan Pharma Co.,Ltd. (SHE:002788)

Luyan Pharma Revenue

Luyan Pharma had revenue of 5.60B CNY in the quarter ending September 30, 2026, with 2.60% growth. This brings the company's total for the last twelve months to 21.57B, up 3.15% year-over-year. In the year 2025, Luyan Pharma had annual revenue of 21.25B with 3.79% growth. That makes Luyan Pharma the 3,613th largest company in the world by revenue and 448th in China.

• Revenue (ttm): 21.57B
• Revenue Growth: +3.15%
• P/S Ratio: 0.17
• Revenue / Employee: 3.77M
• Employees: 5,722
• Market Cap: 3.76B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Wholesale of Medicine 19.11B 90.0%
• Pharmaceutical Retail 1.52B 7.1%
• Pharmaceutical Industry 558.61M 2.6%
• Other 57.35M 0.3%

Fiscal year ended Dec 31, 2025 See the full Luyan Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	21.25B	776.02M	3.79%
Dec 31, 2024	20.47B	625.23M	3.15%
Dec 31, 2023	19.85B	383.03M	1.97%
Jan 1, 2023	19.46B	1.92B	10.93%
Dec 31, 2021	17.55B	2.01B	12.94%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error